OBJECTIVE: To assess the relationships among obesity, insulin sensitivity, and testosterone in pubertal boys. PARTICIPANTS: This study included 20 lean, obese, and type 2 diabetic (T2DM) males, the majority of whom underwent a hyperinsulinemic-euglycemic clamp (n=16). METHODS: Glucose disposal (M value), serum testosterone, and body mass index (BMI) z-score were measured. Differences in testosterone were evaluated by group (lean vs. obese vs. T2DM), while regression was performed to evaluate the relationships among testosterone, obesity and insulin sensitivity. RESULTS: Controlling for Tanner stage, testosterone concentration was significantly lower in obese (p=0.02) and T2DM males (p=0.001) compared to lean males. Furthermore, M value was significantly associated with serum testosterone, even after controlling for BMI and Tanner stage. CONCLUSIONS: These data suggest that obese adolescent boys have lower serum testosterone than controls of the same Tanner stage, and echo the data in adult males associating obesity and insulin resistance with hypogonadism.
OBJECTIVE: To assess the relationships among obesity, insulin sensitivity, and testosterone in pubertal boys. PARTICIPANTS: This study included 20 lean, obese, and type 2 diabetic (T2DM) males, the majority of whom underwent a hyperinsulinemic-euglycemic clamp (n=16). METHODS:Glucose disposal (M value), serum testosterone, and body mass index (BMI) z-score were measured. Differences in testosterone were evaluated by group (lean vs. obese vs. T2DM), while regression was performed to evaluate the relationships among testosterone, obesity and insulin sensitivity. RESULTS: Controlling for Tanner stage, testosterone concentration was significantly lower in obese (p=0.02) and T2DM males (p=0.001) compared to lean males. Furthermore, M value was significantly associated with serum testosterone, even after controlling for BMI and Tanner stage. CONCLUSIONS: These data suggest that obese adolescent boys have lower serum testosterone than controls of the same Tanner stage, and echo the data in adult males associating obesity and insulin resistance with hypogonadism.
Authors: M L Ahmed; K K Ong; D J Morrell; L Cox; N Drayer; L Perry; M A Preece; D B Dunger Journal: J Clin Endocrinol Metab Date: 1999-03 Impact factor: 5.958
Authors: David E Laaksonen; Leo Niskanen; Kari Punnonen; Kristiina Nyyssönen; Tomi-Pekka Tuomainen; Veli-Pekka Valkonen; Riitta Salonen; Jukka T Salonen Journal: Diabetes Care Date: 2004-05 Impact factor: 19.112
Authors: Susan Y Euling; Marcia E Herman-Giddens; Peter A Lee; Sherry G Selevan; Anders Juul; Thorkild I A Sørensen; Leo Dunkel; John H Himes; Grete Teilmann; Shanna H Swan Journal: Pediatrics Date: 2008-02 Impact factor: 7.124
Authors: Luís Rato; Marco G Alves; Sílvia Socorro; Ana I Duarte; José E Cavaco; Pedro F Oliveira Journal: Nat Rev Urol Date: 2012-05-01 Impact factor: 14.432
Authors: Melissa K Crocker; Elizabeth A Stern; Nicole M Sedaka; Lauren B Shomaker; Sheila M Brady; Asem H Ali; Thomas H Shawker; Van S Hubbard; Jack A Yanovski Journal: J Clin Endocrinol Metab Date: 2014-04-29 Impact factor: 5.958
Authors: Maria Chondronikola; Walter J Meyer; Labros S Sidossis; Sylvia Ojeda; Joanna Huddleston; Pamela Stevens; Elisabet Børsheim; Oscar E Suman; Celeste C Finnerty; David N Herndon Journal: J Burn Care Res Date: 2014 Sep-Oct Impact factor: 1.845